The cardiac manifestations of a neuroendocrine tumour are referred to as carcinoid heart disease (CaHD) and are associated with a poor prognosis. Surgical intervention is the only proven …

Carcinoid heart disease (CaHD) is an important complication among patients with metastatic neuroendocrine tumors and carcinoid syndrome (CS). CS patients (25%-65%) eventually …

2024年10月1日 · Transthoracic echocardiography (TTE) remains the gold standard for the diagnosis of CaHD and is a crucial screening modality for detecting CaHD in patients with …

2023年5月20日 · Carcinoid heart disease (CaHD) is an important complication among patients with metastatic neuroendocrine tumors and carcinoid syndrome (CS). CS patients (25%-65%)...

类癌综合征患者的症状和生存率都有所改善，但发展为类癌性心脏病（CaHD）还会继续降低生存率。 本研究旨在分析瓣膜手术治疗CaHD后患者在27年的时间中的治疗效果，确定早期和晚期 …

2020年5月1日 · In the subgroup of patients with carcinoid syndrome, the development of carcinoid heart disease (CaHD) severely impacts long term survival. Valve surgery has been …

2021年11月25日 · 类癌性心脏病（cahd）的发生机制仍未明确。对于基线时没有任何心脏受累的患者，很难确定他们的最佳随访时机。 近日，心血管疾病领域权威杂志jaha上发表了一篇研究 …

Cardiac surgery in patients with CaHD is a complex undertaking, and is the only definitive treatment for symptom management in CaHD with significant survival benefit for patients in …

2023年7月5日 · Carcinoid heart disease (CaHD) is an important complication among patients with metastatic neuroendocrine tumors and carcinoid syndrome (CS). CS patients (25%-65%) …

2021年11月24日 · The main results are (1) CaHD is an ongoing disease involving echocardiographic follow‐up; (2) serotonin plays a key role in the development of CaHD; (3) no …